This inventor holds 1 USPTO granted patent. Top assignee: Helixir Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Jae Ha Ryu: Innovator in Anti-Obesity Compounds
Introduction
Jae Ha Ryu is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of health and wellness through his innovative research. His work primarily focuses on developing compounds that can aid in combating obesity and related health issues.
Latest Patents
Jae Ha Ryu holds a patent for a composition comprising an alcohol compound isolated from the extract of Cucurbitaceae family plants. This invention is particularly noteworthy for its anti-adipogenic and anti-obesity activity. The compound demonstrates potent weight-reducing effects, lowers blood triglyceride and cholesterol levels, activates PPAR α, and prevents adipogenesis in precursor fat cells without toxicity. This extract has potential applications in treating or preventing obesity and diseases associated with adipogenesis, making it a valuable addition to medicine and health care food.
Career Highlights
Throughout his career, Jae Ha Ryu has been dedicated to advancing the understanding of obesity and its treatment. His innovative approach has led to the development of effective solutions that can significantly impact public health. He is currently associated with Helixir Co., Ltd., where he continues to work on groundbreaking research.
Collaborations
Jae Ha Ryu collaborates with talented individuals in his field, including Hyun Jin Jung and Sun Young Kim. These partnerships enhance the research and development process, leading to more effective innovations.
Conclusion
Jae Ha Ryu is a prominent inventor whose work in anti-obesity compounds has the potential to transform health care. His dedication to innovation and collaboration underscores the importance of research in addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile